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CASE REPORT
Cellular angiofibroma of the orbit
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ABSTRACT
Cellular angiofibroma is a benign mesenchymal tumor most commonly located in the distal genital 
tract of both men and women. Although extragenital locations have been reported rarely, this is the 
first report of cellular angiofibroma of the orbit. A 58-year-old man presented with a mass in the left 
superomedial orbit since 2 years. Magnetic resonance imaging showed a well-demarcated lesion 
with a homogeneous intermediate signal intensity on both T1- and T2-weighted images, homo-
geneous contrast enhancement and high signal intensity on diffusion-weighted images. Complete 
excision was performed through a medial upper eyelid crease incision. Histopathology showed 
a vascular CD34-positive and STAT6-negative spindle cell tumor with monoallelic loss of FOXO1, 
indicating cellular angiofibroma.
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Introduction
Cellular angiofibroma was first described as a benign 
mesenchymal tumor of the vulva by Nucci et al.1 Since 
then it has been reported most commonly in the distal 
genital tract of both men and women, although extra-
genital locations have been rarely reported as well.2–8 To 
date, however, no reports have been published on cellu-
lar angiofibroma of the orbit. In this report we describe 
clinical, radiological and histopathological characteris-
tics of a case with cellular angiofibroma of the orbit.
Case report
A 58-year-old man was referred because of a swelling in 
the left superomedial orbit. Medical history included 
hypertension and gout. He had noticed the swelling 
two years earlier. Only little growth had been noted, 
but the lesion caused discomfort and was found to be 
cosmetically disturbing. Magnetic resonance imaging 
(MRI) was ordered by the referring ophthalmologist, 
and performed twice with a 6-month interval. MRI 
revealed a well-demarcated, non-calcified lesion with 
an intermediate signal intensity on both T1- and T2- 
weighted images, with homogeneous enhancement after 
contrast administration and high signal intensity on 
diffusion-weighted images. There was no evidence of 
calcifications. The lesion was classified as a cavernous 
hemangioma, with no evident signs of growth. On clin-
ical examination, a palpable mass was found in the left 
superomedial orbit and the eyelid was diffusely swollen 
(Figure 1). The vertical lid aperture measured 10 mm on 
the right side and 9 mm on the left side with a symmetric 
levator function of 17 mm. There was no exophthalmos 
or non-axial displacement of the globe. Visual acuity was 
20/20 in both eyes and further ophthalmic examination 
was unremarkable. Re-evaluation of the MRI was per-
formed by a radiologist specialized in orbital pathology, 
and concluded that the lesion did not fit the presumed 
diagnosis of cavernous hemangioma due to its location, 
shape and signal characteristics. Definite diagnosis was 
unsure, but due to the restricted diffusion orbital lym-
phoma was suggested (Figure 2). Surgical resection of 
the lesion was performed under general anesthesia 
through a medial upper lid crease incision. Intra- 
operatively it showed to be a smooth tumor that could 
be resected completely without difficulties to acquire 
hemostasis (Figure 3A). Post-operative recovery was 
uneventful (Figure 3B). Histopathology (Figure 4) was 
reviewed by a panel of pathologists specialized in 
ophthalmic and soft tissue pathology and revealed 
a vascular, not atypical, CD34-positive and STAT6- 
negative spindle cell tumor which, based on monoallelic 
loss of FOXO1 by fluorescence in situ hybridization 
(FISH), could be best classified as a cellular 
angiofibroma.
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Discussion
Cellular angiofibroma is a benign mesenchymal 
tumor most commonly located in the distal genital 
tract of both men (inguino-scrotal region) and 
women (vulvo-vaginal region).2,3 Extragenital loca-
tions have been reported rarely and include the 
hypopharynx, nasopharynx, oral mucosa, pelvis, 
hypochondrium, retroperitoneal space, breasts, chest 
and extremities.3–8 In this report, we present the first 
case of cellular angiofibroma located in the orbit.
As in the more common locations, it presented as 
a slowly growing mass, causing only mild discomfort. 
The MRI characteristics of cellular angiofibroma vary 
amongst reports.9–11 As in our case, T1-weighted 
images are mostly found to be of intermediate signal 
intensity, while T2-weighted images can show either 
low, intermediate or high signal intensity. Differences 
in these characteristics may depend on variations in 
the tumor’s histological background such as the 
amount of spindle cells, myxoid and collagenous 
stroma and fat. Similar histological variations may 
also effect contrast enhancement of the tumor: the 
more and more evenly vascularized, the more inten-
sely and homogeneously enhanced by gadolinium 
contrast.9,10 Interestingly, Ntorkou et al found no 
areas of restricted diffusion, while in our case high 
signal was noted on DWI.9
Histologically, we found a vascular CD34-positive 
spindle cell tumor with monoallelic loss of FOXO1. 
The tumor was negative for STAT6 and therefore did 
not fit the diagnosis of giant cell angiofibroma/soli-
tary fibrous tumor. Indeed, cellular angiofibroma is 
typically characterized as a well circumscribed tumor 
composed of bland spindle cells in an edematous to 
fibrous stroma with hypo- and hypercellular areas 
and numerous small- to medium-sized thick-walled 
vessels.2,3 Intralesional fat is found in some but not 
all cellular angiofibromas. Some may show mitotic 
activity but there is typically no necrosis.2,3 Looking 
Figure 1. Presentation. Ophthalmic examination showed a mass 
located in the left superomedial orbit with diffuse swelling of the 
eyelid.
Figure 2. Magnetic resonance imaging. A lobulated mass is appreciated anteriorly within the left superomedial orbit, extending both 
pre- and postseptally, molding around the globe but not infiltrating surrounding structures. The lesion has homogeneous intermediate 
signal intensity on both T1- (A) and T2-weighted (B) images, shows homogeneous enhancement after contrast administration (C), and 
high signal on the diffusion-weighted image (D) with diffusion restriction on the apparent diffusion coefficient (ADC) map (E).
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at immunohistochemical profiles, most tumors are 
CD34 positive and negative for S-100 protein. 
Variable staining profiles are found for SMA, EMA 
and desmin. Interestingly, they may also express 
estrogen and progesterone receptors.2,3 FISH shows 
monoallelic loss of FOXO1 in cellular angiofibroma, 
spindle cell lipoma and mammary-type myofibroblas-
toma, but not in giant cell angiofibroma/solitary 
fibrous tumor.3 The diagnoses of spindle cell lipoma 
and mammary-type myofibroblastoma were rejected 
in the current case based on histopathology. 
Although reports on atypia or sarcomatous transfor-
mation have been made, no such signs were found in 
our patient.12
Treatment of cellular angiofibroma consists of 
simple excision, which even in case of atypia or 
sarcomatous transformation seems to be adequate.3 
In line with these reports, our patient has not shown 
Figure 3. Intra-operative appearance and post-operative result. (A) Complete surgical excision of the lesion was performed through 
a medial upper eyelid crease incision. The lesion did not appear to infiltrate surrounding tissues. (B) Post-operative recovery was 
uneventful.
Figure 4. Histopathology, immunohistochemistry and FISH. (A) Histopathology reveals both fatty and connective tissue with a cellular 
and vascular proliferation of spindle cells with little eosinophilic cytoplasm and oval nuclei with a fine chromatin pattern and 
prominent or sometimes double nucleoli. Nuclei are only slightly polymorphic. Diffusely scattered are vascular spaces covered with 
endothelium that is flattened and not atypical. There are no mitotic figures or necrosis. (Displayed: 200x Hematotoxylin and Eosin 
staining)(B) Immunohistochemistry was diffusely positive for CD34, cytoplasmatic WT-1 and factor XIIIa. S100 was questionably 
positive. Stainings were negative for STAT6, EMA, SMA, GLUT1, CD31, HMB45, SOX10, Melan A, ERG, desmin and pankeratin. (Displayed: 
200x CD34 staining)(C) Only luminal endothelium of the vascular spaces stains positive for the endothelial marker ERG, the spindle cells 
are negative (Displayed: 200x ERG staining)(D) Fluorescence in situ hybridization (FISH) shows mono allelic loss of FOXO1 using a split 
apart probe. Single closely related green and red signals can be observed for each nucleus indicating complete loss of one gene and 
a normal configuration of the remaining signal.
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any signs of recurrence during 11 months of follow- 
up.
In conclusion, cellular angiofibroma is a benign 
mesenchymal tumor that deserves a place in the differ-
ential diagnosis of solid tumors in the orbit. Clinical and 
histopathological characteristics resemble those of cellu-
lar angiofibroma found elsewhere in the body.
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